Thanks Lozza. Current price $2.77-$2.80
Market values: post 5948, Ozestock:
Item 3.2 The Share value of only NV07a and Isoflavones is estimated at $ 9.55. This is based on a P/E of 20.
Now apply a P/E of 15 instead and give a massive discount of 50%: The Investor then ought to be paying $3.58 IMHO.
The Phenox trials have been excluded as is the cash held by Novogen (was $35 mill. on 1 Jan. 2003).
Also excluded are the very promising NV04 drug as well as others. And so are the know-how, the calibre of the Scientists, the very good connections with Research Institutes and Hospitals and the Infrastructure. All that is free!
Therefore the current price doesn't even approach a minimum of the mentioned $3.58 and this after a massive 50% discount.
We are waiting for news of the Commercialisation of drug NV07a and the Primary defensible Patent for Isoflavones.
The latter will enable Novogen to charge royalties.
Investors, please do your own research before investing.
Gerry
- Forums
- ASX - By Stock
- KZA
- estimates and market values
estimates and market values, page-7
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online